W-372 F-18

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 341574

CAS#: 1206722-92-0

Description: W-372 F-18 is a biochemical.

Chemical Structure

W-372 F-18
CAS# 1206722-92-0

Theoretical Analysis

MedKoo Cat#: 341574
Name: W-372 F-18
CAS#: 1206722-92-0
Chemical Formula: C14H918FN4OS
Exact Mass: 299.0506
Molecular Weight: 299.3139
Elemental Analysis: C, 56.18; H, 3.03; F, 6.01; N, 18.72; O, 5.35; S, 10.71

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: W-372 F-18.

IUPAC/Chemical Name: Imidazo(2',1':2,3)thiazolo(5,4-b)pyridine, 2-(6-(fluoro-18F)-3-pyridinyl)-7-methoxy-


InChi Code: InChI=1S/C14H9FN4OS/c1-20-12-5-3-10-13(18-12)21-14-17-9(7-19(10)14)8-2-4-11(15)16-6-8/h2-7H,1H3/i15-1

SMILES Code: COC1=CC=C2C(SC3=NC(C4=CC=C([18F])N=C4)=CN32)=N1

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 299.3139 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Lee JW, Lee HS, Na JO, Lee SM. Effect of adipose tissue volume on prognosis in patients with non-small cell lung cancer. Clin Imaging. 2018 May 4;50:308-313. doi: 10.1016/j.clinimag.2018.05.006. [Epub ahead of print] PubMed PMID: 29751203.

2: Sah BR, Leissing CA, Delso G, Ter Voert EE, Krieg S, Leibl S, Schneider PM, Reiner CS, Hüllner MW, Veit-Haibach P. Evaluation of multifunctional imaging parameters in gastro-oesophageal cancer using F-18-FDG-PET/CT with integrated perfusion CT. Q J Nucl Med Mol Imaging. 2018 May 10. doi: 10.23736/S1824-4785.18.03067-4. [Epub ahead of print] PubMed PMID: 29745630.

3: Beinat C, Haywood T, Chen YS, Patel CB, Alam IS, Murty S, Gambhir SS. The Utility of [(18)F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography. Mol Imaging Biol. 2018 May 7. doi: 10.1007/s11307-018-1194-y. [Epub ahead of print] PubMed PMID: 29736561.

4: Rogasch JMM, Hundsdoerfer P, Hofheinz F, Wedel F, Schatka I, Amthauer H, Furth C. Pretherapeutic FDG-PET total metabolic tumor volume predicts response to induction therapy in pediatric Hodgkin's lymphoma. BMC Cancer. 2018 May 3;18(1):521. doi: 10.1186/s12885-018-4432-4. PubMed PMID: 29724189; PubMed Central PMCID: PMC5934894.

5: Cuccurullo V, Di Stasio GD, Mansi L. Nuclear Medicine in Prostate Cancer: A New Era for Radiotracers. World J Nucl Med. 2018 Apr-Jun;17(2):70-78. doi: 10.4103/wjnm.WJNM_54_17. Review. PubMed PMID: 29719480; PubMed Central PMCID: PMC5905261.

6: Zhang C, Zhang Z, Lin KS, Lau J, Zeisler J, Colpo N, Perrin DM, Bénard F. Melanoma Imaging Using (18)F-Labeled α-Melanocyte-Stimulating Hormone Derivatives with Positron Emission Tomography. Mol Pharm. 2018 May 10. doi: 10.1021/acs.molpharmaceut.7b01113. [Epub ahead of print] PubMed PMID: 29714486.

7: Koç ZP, Kara PÖ, Dağtekin A. Detection of unknown primary tumor in patients presented with brain metastasis by F-18 fluorodeoxyglucose positron emission tomography/computed tomography. CNS Oncol. 2018 Apr;7(2):CNS12. doi: 10.2217/cns-2017-0018. Epub 2018 Apr 30. PubMed PMID: 29708403.

8: Sala-Rabanal M, Ghezzi C, Hirayama BA, Kepe V, Liu J, Barrio JR, Wright EM. Intestinal absorption of glucose in mice as determined by positron emission tomography. J Physiol. 2018 Apr 29. doi: 10.1113/JP275934. [Epub ahead of print] PubMed PMID: 29707805.

9: Lee Y, Kroemer NB, Oehme L, Beuthien-Baumann B, Goschke T, Smolka MN. Lower dopamine tone in the striatum is associated with higher body mass index. Eur Neuropsychopharmacol. 2018 Apr 25. pii: S0924-977X(18)30072-5. doi: 10.1016/j.euroneuro.2018.03.009. [Epub ahead of print] PubMed PMID: 29705023.

10: Loewenstein DA, Curiel RE, Rosselli M, Penate A, Greig-Custo MT, Bauer RM, Guinjoan SM, Hanson KS, Li C, Lizarraga G, Barker WW, Torres V, DeKosky S, Adjouadi M, Duara R. Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness. Curr Alzheimer Res. 2018 Apr 27. doi: 10.2174/1567205015666180427122746. [Epub ahead of print] PubMed PMID: 29701153.

11: Chen HH, Fu BT, Zhu QY, Lu HX, Luo LH, Chen L, Liu XH, Zhou XJ, Huang JH, Feng XX, Shan GS, Shen ZY. [Dynamic variations of BMI and influencing factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Liuzhou, Guangxi Zhuang Autonomous Region, 2013-2014]. Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Apr 10;39(4):487-490. doi: 10.3760/cma.j.issn.0254-6450.2018.04.020. Chinese. PubMed PMID: 29699043.

12: Yoon HJ, Kim BS, Moon CM, Yoo J, Lee KE, Kim Y. Prognostic value of diffuse splenic FDG uptake on PET/CT in patients with gastric cancer. PLoS One. 2018 Apr 26;13(4):e0196110. doi: 10.1371/journal.pone.0196110. eCollection 2018. PubMed PMID: 29698422; PubMed Central PMCID: PMC5919642.

13: Takemiya K, Ning X, Seo W, Wang X, Mohammad R, Joseph G, Titterington JS, Kraft CS, Nye JA, Murthy N, Goodman MM, Taylor WR. Novel PET and Near Infrared Imaging Probes for the Specific Detection of Bacterial Infections Associated With Cardiac Devices. JACC Cardiovasc Imaging. 2018 Apr 13. pii: S1936-878X(18)30207-9. doi: 10.1016/j.jcmg.2018.02.011. [Epub ahead of print] PubMed PMID: 29680350.

14: Wei K, Pan B, Yang H, Lu C, Ge L, Cao N. F-18 FDG PET, CT, and MRI for detecting the malignant potential in patients with gastrointestinal stromal tumors: A protocol for a network meta-analysis of diagnostic test accuracy. Medicine (Baltimore). 2018 Apr;97(16):e0389. doi: 10.1097/MD.0000000000010389. PubMed PMID: 29668594; PubMed Central PMCID: PMC5916653.

15: Yoon SN. Follicular Lymphoma mimicking Metastatic Nodes on the F-18 FDG PET/CT and MRI for Staging of Endometrial Cancer. Nucl Med Mol Imaging. 2018 Apr;52(2):159-161. doi: 10.1007/s13139-016-0458-1. Epub 2016 Nov 5. PubMed PMID: 29662565; PubMed Central PMCID: PMC5897253.

16: Choi JH, Byun BH, Lim I, Moon H, Park J, Chang KJ, Kim BI, Choi CW, Lim SM. The Predictive Values of Lesion Size, F-18 FDG Avidity and I-131 Avidity for the Clinical Outcome of I-131 Treatment in Patients with Metastatic Differentiated Thyroid Carcinoma Only in the Lung. Nucl Med Mol Imaging. 2018 Apr;52(2):135-143. doi: 10.1007/s13139-017-0502-9. Epub 2017 Nov 7. PubMed PMID: 29662562; PubMed Central PMCID: PMC5897259.

17: Riff C, Guilhaumou R, Marsot A, Beaussier M, Cohen M, Blin O, Francon D. Ropivacaine Wound Infiltration for Pain Management After Breast Cancer Mastectomy: A Population Pharmacokinetic Analysis. Clin Pharmacol Drug Dev. 2018 Apr 16. doi: 10.1002/cpdd.452. [Epub ahead of print] PubMed PMID: 29659182.

18: Kang YK, Song YS, Cho S, Jheon S, Lee WW, Kim K, Kim SE. Prognostic stratification model for patients with stage I non-small cell lung cancer adenocarcinoma treated with surgical resection without adjuvant therapies using metabolic features measured on F-18 FDG PET and postoperative pathologic factors. Lung Cancer. 2018 May;119:1-6. doi: 10.1016/j.lungcan.2018.02.013. Epub 2018 Mar 2. PubMed PMID: 29656743.

19: Toriihara A, Nakadate M, Fujioka T, Oyama J, Tsutsumi T, Asakage T, Tsunoda A, Tateishi U. Clinical Usefulness of 18F-FDG PET/CT for Staging Cancer of the External Auditory Canal. Otol Neurotol. 2018 Jun;39(5):e370-e375. doi: 10.1097/MAO.0000000000001791. PubMed PMID: 29649045.

20: Natarajan A, Chandra P, Purandare N, Agrawal A, Shah S, Puranik A, Rangarajan V. Role of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Various Orbital Malignancies. Indian J Nucl Med. 2018 Apr-Jun;33(2):118-124. doi: 10.4103/ijnm.IJNM_135_17. PubMed PMID: 29643671; PubMed Central PMCID: PMC5883428.